3.7.0.1 html 185 249 1 false 48 0 false 10 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.vikingtherapeutics.com/20170630/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 100010 - Statement - Balance Sheets Sheet http://www.vikingtherapeutics.com/20170630/taxonomy/role/StatementBalanceSheets Balance Sheets Statements 2 false false R3.htm 100020 - Statement - Balance Sheets (Parenthetical) Sheet http://www.vikingtherapeutics.com/20170630/taxonomy/role/StatementBalanceSheetsParenthetical Balance Sheets (Parenthetical) Statements 3 false false R4.htm 100030 - Statement - Statements of Operations and Comprehensive Loss (Unaudited) Sheet http://www.vikingtherapeutics.com/20170630/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLossUnaudited Statements of Operations and Comprehensive Loss (Unaudited) Statements 4 false false R5.htm 100040 - Statement - Statements of Cash Flows (Unaudited) Sheet http://www.vikingtherapeutics.com/20170630/taxonomy/role/StatementStatementsOfCashFlowsUnaudited Statements of Cash Flows (Unaudited) Statements 5 false false R6.htm 100050 - Disclosure - Organization, Liquidity and Management's Plan, and Summary of Significant Accounting Policies Sheet http://www.vikingtherapeutics.com/20170630/taxonomy/role/DisclosureOrganizationLiquidityAndManagementSPlanAndSummaryOfSignificantAccountingPolicies Organization, Liquidity and Management's Plan, and Summary of Significant Accounting Policies Notes 6 false false R7.htm 100060 - Disclosure - Investments in Marketable Securities Sheet http://www.vikingtherapeutics.com/20170630/taxonomy/role/DisclosureInvestmentsInMarketableSecurities Investments in Marketable Securities Notes 7 false false R8.htm 100070 - Disclosure - Fair Value of Financial Instruments Sheet http://www.vikingtherapeutics.com/20170630/taxonomy/role/DisclosureFairValueOfFinancialInstruments Fair Value of Financial Instruments Notes 8 false false R9.htm 100080 - Disclosure - Convertible Notes Payable Notes http://www.vikingtherapeutics.com/20170630/taxonomy/role/DisclosureConvertibleNotesPayable Convertible Notes Payable Notes 9 false false R10.htm 100090 - Disclosure - Stockholders' Equity Sheet http://www.vikingtherapeutics.com/20170630/taxonomy/role/DisclosureStockholdersEquity Stockholders' Equity Notes 10 false false R11.htm 100100 - Disclosure - Stock-Based Compensation Sheet http://www.vikingtherapeutics.com/20170630/taxonomy/role/DisclosureStockBasedCompensation Stock-Based Compensation Notes 11 false false R12.htm 100110 - Disclosure - Warrants Sheet http://www.vikingtherapeutics.com/20170630/taxonomy/role/DisclosureWarrants Warrants Notes 12 false false R13.htm 100120 - Disclosure - Commitments and Contingencies Sheet http://www.vikingtherapeutics.com/20170630/taxonomy/role/DisclosureCommitmentsAndContingencies Commitments and Contingencies Notes 13 false false R14.htm 100130 - Disclosure - Subsequent Events Sheet http://www.vikingtherapeutics.com/20170630/taxonomy/role/DisclosureSubsequentEvents Subsequent Events Notes 14 false false R15.htm 100140 - Disclosure - Organization, Liquidity and Management's Plan, and Summary of Significant Accounting Policies (Policies) Sheet http://www.vikingtherapeutics.com/20170630/taxonomy/role/DisclosureOrganizationLiquidityAndManagementSPlanAndSummaryOfSignificantAccountingPoliciesPolicies Organization, Liquidity and Management's Plan, and Summary of Significant Accounting Policies (Policies) Policies http://www.vikingtherapeutics.com/20170630/taxonomy/role/DisclosureOrganizationLiquidityAndManagementSPlanAndSummaryOfSignificantAccountingPolicies 15 false false R16.htm 100150 - Disclosure - Organization, Liquidity and Management's Plan, and Summary of Significant Accounting Policies (Tables) Sheet http://www.vikingtherapeutics.com/20170630/taxonomy/role/DisclosureOrganizationLiquidityAndManagementSPlanAndSummaryOfSignificantAccountingPoliciesTables Organization, Liquidity and Management's Plan, and Summary of Significant Accounting Policies (Tables) Tables http://www.vikingtherapeutics.com/20170630/taxonomy/role/DisclosureOrganizationLiquidityAndManagementSPlanAndSummaryOfSignificantAccountingPolicies 16 false false R17.htm 100160 - Disclosure - Investments in Marketable Securities (Tables) Sheet http://www.vikingtherapeutics.com/20170630/taxonomy/role/DisclosureInvestmentsInMarketableSecuritiesTables Investments in Marketable Securities (Tables) Tables http://www.vikingtherapeutics.com/20170630/taxonomy/role/DisclosureInvestmentsInMarketableSecurities 17 false false R18.htm 100170 - Disclosure - Fair Value of Financial Instruments (Tables) Sheet http://www.vikingtherapeutics.com/20170630/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsTables Fair Value of Financial Instruments (Tables) Tables http://www.vikingtherapeutics.com/20170630/taxonomy/role/DisclosureFairValueOfFinancialInstruments 18 false false R19.htm 100180 - Disclosure - Convertible Notes Payable (Tables) Notes http://www.vikingtherapeutics.com/20170630/taxonomy/role/DisclosureConvertibleNotesPayableTables Convertible Notes Payable (Tables) Tables http://www.vikingtherapeutics.com/20170630/taxonomy/role/DisclosureConvertibleNotesPayable 19 false false R20.htm 100190 - Disclosure - Stock-Based Compensation (Tables) Sheet http://www.vikingtherapeutics.com/20170630/taxonomy/role/DisclosureStockBasedCompensationTables Stock-Based Compensation (Tables) Tables http://www.vikingtherapeutics.com/20170630/taxonomy/role/DisclosureStockBasedCompensation 20 false false R21.htm 100200 - Disclosure - Commitments and Contingencies (Tables) Sheet http://www.vikingtherapeutics.com/20170630/taxonomy/role/DisclosureCommitmentsAndContingenciesTables Commitments and Contingencies (Tables) Tables http://www.vikingtherapeutics.com/20170630/taxonomy/role/DisclosureCommitmentsAndContingencies 21 false false R22.htm 100210 - Disclosure - Organization, Liquidity and Management's Plan, and Summary of Significant Accounting Policies - Additional Information (Detail) Sheet http://www.vikingtherapeutics.com/20170630/taxonomy/role/DisclosureOrganizationLiquidityAndManagementSPlanAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail Organization, Liquidity and Management's Plan, and Summary of Significant Accounting Policies - Additional Information (Detail) Details 22 false false R23.htm 100220 - Disclosure - Organization, Liquidity and Management's Plan, and Summary of Significant Accounting Policies - Schedule of Computation of Basic and Diluted Net Loss per Common Share (Detail) Sheet http://www.vikingtherapeutics.com/20170630/taxonomy/role/DisclosureOrganizationLiquidityAndManagementSPlanAndSummaryOfSignificantAccountingPoliciesScheduleOfComputationOfBasicAndDilutedNetLossPerCommonShareDetail Organization, Liquidity and Management's Plan, and Summary of Significant Accounting Policies - Schedule of Computation of Basic and Diluted Net Loss per Common Share (Detail) Details 23 false false R24.htm 100230 - Disclosure - Organization, Liquidity and Management's Plan, and Summary of Significant Accounting Policies - Schedule of Potentially Dilutive Securities Not Included in Calculation of Diluted Net Loss per Share (Detail) Sheet http://www.vikingtherapeutics.com/20170630/taxonomy/role/DisclosureOrganizationLiquidityAndManagementSPlanAndSummaryOfSignificantAccountingPoliciesScheduleOfPotentiallyDilutiveSecuritiesNotIncludedInCalculationOfDilutedNetLossPerShareDetail Organization, Liquidity and Management's Plan, and Summary of Significant Accounting Policies - Schedule of Potentially Dilutive Securities Not Included in Calculation of Diluted Net Loss per Share (Detail) Details 24 false false R25.htm 100240 - Disclosure - Investments in Marketable Securities - Additional Information (Detail) Sheet http://www.vikingtherapeutics.com/20170630/taxonomy/role/DisclosureInvestmentsInMarketableSecuritiesAdditionalInformationDetail Investments in Marketable Securities - Additional Information (Detail) Details 25 false false R26.htm 100250 - Disclosure - Investments in Marketable Securities - Summary of Investments Classified As Available-For-Sale Securities (Detail) Sheet http://www.vikingtherapeutics.com/20170630/taxonomy/role/DisclosureInvestmentsInMarketableSecuritiesSummaryOfInvestmentsClassifiedAsAvailableForSaleSecuritiesDetail Investments in Marketable Securities - Summary of Investments Classified As Available-For-Sale Securities (Detail) Details 26 false false R27.htm 100260 - Disclosure - Investments in Marketable Securities - Summary of Investments Classified As Available-For-Sale Securities (Parenthetical) (Detail) Sheet http://www.vikingtherapeutics.com/20170630/taxonomy/role/DisclosureInvestmentsInMarketableSecuritiesSummaryOfInvestmentsClassifiedAsAvailableForSaleSecuritiesParentheticalDetail Investments in Marketable Securities - Summary of Investments Classified As Available-For-Sale Securities (Parenthetical) (Detail) Details 27 false false R28.htm 100270 - Disclosure - Fair Value of Financial Instruments - Summary of Fair Values of Financial Instruments (Detail) Sheet http://www.vikingtherapeutics.com/20170630/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValuesOfFinancialInstrumentsDetail Fair Value of Financial Instruments - Summary of Fair Values of Financial Instruments (Detail) Details 28 false false R29.htm 100290 - Disclosure - Fair Value of Financial Instruments - Summary of Changes in Debt Conversion Feature Liabilities Measured at Fair Value on Recurring Basis Using Significant Unobservable Inputs (Detail) Sheet http://www.vikingtherapeutics.com/20170630/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsSummaryOfChangesInDebtConversionFeatureLiabilitiesMeasuredAtFairValueOnRecurringBasisUsingSignificantUnobservableInputsDetail Fair Value of Financial Instruments - Summary of Changes in Debt Conversion Feature Liabilities Measured at Fair Value on Recurring Basis Using Significant Unobservable Inputs (Detail) Details 29 false false R30.htm 100300 - Disclosure - Fair Value of Financial Instruments - Schedule of Valuation Techniques and Significant Unobservable Inputs Used to Determine Fair Value of Significant Level 3 Liabilities (Detail) Sheet http://www.vikingtherapeutics.com/20170630/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsScheduleOfValuationTechniquesAndSignificantUnobservableInputsUsedToDetermineFairValueOfSignificantLevel3LiabilitiesDetail Fair Value of Financial Instruments - Schedule of Valuation Techniques and Significant Unobservable Inputs Used to Determine Fair Value of Significant Level 3 Liabilities (Detail) Details 30 false false R31.htm 100310 - Disclosure - Convertible Notes Payable - Schedule of Convertible Notes Payable (Detail) Notes http://www.vikingtherapeutics.com/20170630/taxonomy/role/DisclosureConvertibleNotesPayableScheduleOfConvertibleNotesPayableDetail Convertible Notes Payable - Schedule of Convertible Notes Payable (Detail) Details 31 false false R32.htm 100320 - Disclosure - Convertible Notes Payable - Schedule of Convertible Notes Payable (Parenthetical) (Detail) Notes http://www.vikingtherapeutics.com/20170630/taxonomy/role/DisclosureConvertibleNotesPayableScheduleOfConvertibleNotesPayableParentheticalDetail Convertible Notes Payable - Schedule of Convertible Notes Payable (Parenthetical) (Detail) Details 32 false false R33.htm 100330 - Disclosure - Convertible Notes Payable - Additional Information (Detail) Notes http://www.vikingtherapeutics.com/20170630/taxonomy/role/DisclosureConvertibleNotesPayableAdditionalInformationDetail Convertible Notes Payable - Additional Information (Detail) Details 33 false false R34.htm 100340 - Disclosure - Stockholders' Equity - Additional Information (Detail) Sheet http://www.vikingtherapeutics.com/20170630/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetail Stockholders' Equity - Additional Information (Detail) Details 34 false false R35.htm 100350 - Disclosure - Stock-Based Compensation - Additional Information (Detail) Sheet http://www.vikingtherapeutics.com/20170630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail Stock-Based Compensation - Additional Information (Detail) Details 35 false false R36.htm 100360 - Disclosure - Stock-Based Compensation - Summary of Stock-based Compensation Expense Recognized (Detail) Sheet http://www.vikingtherapeutics.com/20170630/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseRecognizedDetail Stock-Based Compensation - Summary of Stock-based Compensation Expense Recognized (Detail) Details 36 false false R37.htm 100370 - Disclosure - Stock-Based Compensation - Schedule of Unrecognized Stock-based Compensation Expense, Net of Estimated Forfeitures, by Type of Award and Weighted-average Recognition Period (Detail) Sheet http://www.vikingtherapeutics.com/20170630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfUnrecognizedStockBasedCompensationExpenseNetOfEstimatedForfeituresByTypeOfAwardAndWeightedAverageRecognitionPeriodDetail Stock-Based Compensation - Schedule of Unrecognized Stock-based Compensation Expense, Net of Estimated Forfeitures, by Type of Award and Weighted-average Recognition Period (Detail) Details 37 false false R38.htm 100380 - Disclosure - Stock-Based Compensation - Summary of Restricted Stock Activity (Detail) Sheet http://www.vikingtherapeutics.com/20170630/taxonomy/role/DisclosureStockBasedCompensationSummaryOfRestrictedStockActivityDetail Stock-Based Compensation - Summary of Restricted Stock Activity (Detail) Details 38 false false R39.htm 100390 - Disclosure - Stock-Based Compensation - Summary of Restricted Stock Units Activity (Detail) Sheet http://www.vikingtherapeutics.com/20170630/taxonomy/role/DisclosureStockBasedCompensationSummaryOfRestrictedStockUnitsActivityDetail Stock-Based Compensation - Summary of Restricted Stock Units Activity (Detail) Details 39 false false R40.htm 100400 - Disclosure - Stock-Based Compensation - Summary of Stock Option Activity (Detail) Sheet http://www.vikingtherapeutics.com/20170630/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetail Stock-Based Compensation - Summary of Stock Option Activity (Detail) Details 40 false false R41.htm 100410 - Disclosure - Stock-Based Compensation - Schedule of Weighted Average Assumptions using Black-Scholes Option Pricing Model (Detail) Sheet http://www.vikingtherapeutics.com/20170630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfWeightedAverageAssumptionsUsingBlackScholesOptionPricingModelDetail Stock-Based Compensation - Schedule of Weighted Average Assumptions using Black-Scholes Option Pricing Model (Detail) Details 41 false false R42.htm 100420 - Disclosure - Warrants - Additional Information (Detail) Sheet http://www.vikingtherapeutics.com/20170630/taxonomy/role/DisclosureWarrantsAdditionalInformationDetail Warrants - Additional Information (Detail) Details 42 false false R43.htm 100430 - Disclosure - Commitments and Contingencies - Additional Information (Detail) Sheet http://www.vikingtherapeutics.com/20170630/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail Commitments and Contingencies - Additional Information (Detail) Details 43 false false R44.htm 100440 - Disclosure - Commitments and Contingencies - Summary of Future Minimum Payments for Sublease (Detail) Sheet http://www.vikingtherapeutics.com/20170630/taxonomy/role/DisclosureCommitmentsAndContingenciesSummaryOfFutureMinimumPaymentsForSubleaseDetail Commitments and Contingencies - Summary of Future Minimum Payments for Sublease (Detail) Details 44 false false R45.htm 100450 - Disclosure - Subsequent Events - Additional Information (Detail) Sheet http://www.vikingtherapeutics.com/20170630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail Subsequent Events - Additional Information (Detail) Details 45 false false All Reports Book All Reports vktx-20170630.xml vktx-20170630.xsd vktx-20170630_cal.xml vktx-20170630_def.xml vktx-20170630_lab.xml vktx-20170630_pre.xml true true